SDS Biotech K.K. Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 2016
SDS Biotech K.K. reported consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported net sales of ¥4,229 million against ¥3,673 million a year ago. Operating income was ¥531 million against ¥405 million a year ago. Ordinary income was ¥458 million against ¥338 million a year ago. Net income was ¥320 million or ¥40.92 per diluted share against ¥210 million or ¥26.83 per diluted share a year ago. Net income before taxes was ¥338,826,000 against ¥460,360,000 a year ago.
The company provided consolidated earnings guidance for the fiscal year ending March 2016. For the year, the company expects to report net sales of ¥20,880 million, operating income of ¥2,170 million, ordinary income of ¥1,800 million and net income of ¥1,100 million or ¥140.46 per share.